Fulgent Genetics
FLGT
196 hedge funds and large institutions have $509M invested in Fulgent Genetics in 2020 Q4 according to their latest regulatory filings, with 88 funds opening new positions, 69 increasing their positions, 28 reducing their positions, and 17 closing their positions.
418% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 17
146% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 28
59% more capital invested
Capital invested by funds: $321M → $509M (+$188M)
56% more funds holding
Funds holding: 126 → 196 (+70)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
3.58% more ownership
Funds ownership: 36.56% → 40.14% (+3.6%)
33% less call options, than puts
Call options by funds: $33.6M | Put options by funds: $50.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$11.8M |
| 3 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
+$10.5M |
| 4 |
Morgan Stanley
New York
|
+$6.18M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJT
Raymond James Trust
St. Petersburg,
Florida
|
-$37.7M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$4.53M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$2.97M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.12M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.67M |
FLGT Hedge Fund Activity: Q4 2020 in Review
196 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2020, worth a combined $509M — up 59% from $321M a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new FLGT positions and 17 closed out — a net gain of 71 holders — while 69 added to existing stakes and 28 trimmed.
The largest buyer was BlackRock, adding an estimated $16.6M. The largest seller was Raymond James Trust, cutting an estimated $37.7M.
- 196 institutional investors held Fulgent Genetics (FLGT) as of Q4 2020, up from 126 in Q3 2020.
- Funds reported $509M of Fulgent Genetics stock for Q4 2020, up 59% quarter-over-quarter.
- 88 funds opened new Fulgent Genetics positions in Q4 2020 and 17 closed out, a net change of +71 holders.
- The largest Fulgent Genetics buyer in Q4 2020 was BlackRock, an estimated $16.6M added.
- The largest Fulgent Genetics seller in Q4 2020 was Raymond James Trust, an estimated $37.7M sold.
Based on aggregated 13F filings for Q4 2020.